Doctors from all over the world pay attention to timely prophylaxis and diagnostics because at the early stages this disease is treated much easier.
Details →
Germany, a global leader in advanced cancer care, offers innovative bone metastases treatments that enhance patient outcomes and quality of life, attracting individuals worldwide.
Details →
Germany, a global leader in advanced cancer care, excels in applying dendritic cell therapy to treat multiple malignancies, attracting cancer patients worldwide.
Details →
Germany, a leader in innovative cancer treatments, is at the forefront of advancing these therapeutic advancements through cutting-edge clinical trials.
Details →
Dendritic cell therapy is redefining lung cancer treatment by leveraging the immune system to combat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
Details →
Germany, a global hub for advanced liver cancer care, is reshaping treatment outcomes with innovative therapeutic breakthroughs, attracting liver cancer worldwide.
Details →
Lutetium Lu-177 PSMA therapy, a cutting-edge targeted radioligand therapy, is transforming the landscape of advanced prostate cancer treatment by delivering precise radiation to cancer cells
Details →
Breakthrough interventional radiology cancer treatment is transforming lives with remarkable patient outcomes and minimal recovery time.
Details →
Pancreatic cancer (ICD C25) is one of the most common gastrointestinal cancers. More than 300,000 new cases are diagnosed in the world every year.
Details →
Duodenal cancer is a rare but serious malignancy that develops in the first portion of your small intestine (duodenum), accounting for less than 1% of all gastrointestinal cancers [3].
Details →
Cancer cells may break away from a tumor in the colon or rectum and spread to other parts of the body through the bloodstream or lymphatic system. These cells may settle and form new tumors on a different organ
Details →
Colon cancer (ICD C18) is one of the five most common malignant tumors in the world, ranking third overall. While the average age of most patients is 60-75 years, the disease can also develop in individuals between 35-50 years old.
Details →
Pancreatic cancer is an aggressive tumor of the digestive system. One of the reasons for the low effectiveness of treatment for pancreatic tumors is the weak anti-tumor immune response.
Details →
A Klatskin tumor, also known as perihilar cancer, is a type of extrahepatic cholangiocarcinoma, which starts in the area where the right and left bile ducts converge to form the common bile duct.
Details →
Kidney cancer, particularly renal cell carcinoma (RCC), remains a formidable challenge, necessitating innovative treatments to enhance outcomes for kidney cancer patients.
Details →
Conventional treatment for pulmonary fibrosis offers limited hope, slowing progression but never reversing damage or restoring lung function.
Details →
Kidney cancer, particularly renal cell carcinoma (RCC), is a significant health challenge requiring innovative approaches to improve outcomes for kidney cancer patients.
Details →
Lung cancer, one of the leading causes of cancer-related deaths globally, demands innovative approaches to improve survival rates and quality of life.
Details →
Dendritic cell therapy, a cornerstone of modern immunotherapy, is revolutionizing cancer treatment by harnessing the immune system to target tumors.
Details →
